Tag: markets

India Medical Tourism Markets Report 2022: A $35.12 Billion Market by 2027
Company Logo

Indian Medical Tourism Market

Indian Medical Tourism Market

Dublin, Nov. 21, 2022 (GLOBE NEWSWIRE) — The “India Medical Tourism Market, Share, Forecast, Industry Trends, Size, Growth, Outlooks, Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

India Medical Tourism Market is expected to generate US$ 35.12 Billion in 2027 from US$ 5.63 Billion in 2021, on account of international medical tourist arrivals in 2027

India also has a long and illustrious medical history dating back to the Vedic era. One of the oldest medical systems, Ayurveda, dates back to 8000 BCE. Since independence, India’s advancement in modern medicine has accelerated; it has built a unique environment for holistic health that incorporates the finest of contemporary healthcare, alternative medicine, and wellness.

As a result, India is considered one of the best locations for Medical Tourism due to the synergy of this unique holistic health and wellness ecosystem and its various possibilities.

India Medical Tourism Market is expected to expand at a CAGR of 35.68{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} from 2021-2027

The primary goal of Indian medical infrastructure is to market India as a high-quality healthcare destination for people worldwide, allowing them to make use of the country’s healthcare knowledge and facilities.

Furthermore, India offers international-standard medical and health services relatively reasonably. Ayurveda Centres are becoming a standard feature in most hotels and resorts. The majority of foreign visitors now come to India only for Ayurveda treatments. Ayurveda has been included in top tour operators’ brochures promoting health tourism worldwide.

By Country, India Medical Tourism – Market and Arrivals

The southern states of India, particularly Kerala, have developed Health Tourism as one of the products for promoting tourism in Kerala. Health tourism has also been announced as one of the state’s differentiators.

The report found that India receives medical tourists from critical countries such as Bangladesh, Iraq, Maldives, Afghanistan, Oman, Yemen, Sudan, Kenya, and Nigeria. Furthermore, we believe that India has a significant opportunity to recognize and aggressively pursue medical tourists from other world regions, including Europe and the Americas.

India Medical Tourism Market during the COVID and post-COVID world

Over the years, the global population, which desperately needs adequate health and wellness solutions, has made medical tourism in India a priority sector with sizable revenue prospects. The COVID-19 pandemic suspended the market’s escalating popularity and growing demand for medical tourism.

Demand for healthy living, preventive medicine, nutrition, and immunity-building visits are expected to rise in the coming years. As a result, healthcare and wellness services are likely to increase in the post-COVID world as more people seek out avenues of quality medical care and holistic health.

Key Advantages of India for Medical Tourism Market are as follows
- The world-class doctors and hospitals.
- The cost of the treatment is a fraction of the price in the source markets.
- There is no waiting period for various medical processes.
- Increasing popularity of India as a medical tourist destination in the African, Middle East & Asian countries.
- Eastern Healthcare Wisdom along with the expertise of Western Medicine.
Key Topics Covered:

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges

5. India Medical Tourism Market

6. India Medical Tourist Arrivals

7. India Medical Tourism Share Analysis
7.1 By Country Market Share
7.2 By Region Market Share

8. Medical Tourist Arrivals by Country, 2017-2020
8.1 France
8.2 Germany
8.3 Italy
8.4 Netherlands
8.5 Norway
8.6 Sweden
8.7 Switzerland
8.8 Kazakhstan
8.9 Russian Federation
8.10 Ukraine
8.11 Egypt
8.12 South Africa
8.13 Bahrain
8.14 Oman
8.15 Turkey
8.16 United Arab Emirates
8.17 Afghanistan
8.18 Iran
8.19 Pakistan
8.20 Indonesia
8.21 Malaysia
8.22 Philippines
8.23 Singapore
8.24 Australia
8.25 New Zealand

9. North America – Country Wise Medical Tourist Arrivals, Market
9.1 Canada
9.2 United States

10. Western Europe – Country Wise Medical Tourist Arrivals, Market
10.1 United Kingdom

11. Eastern Europe – Medical Tourist Arrivals, Market
11.1 Arrivals
11.2 Market

12. Africa – Country Wise Medical Tourist Arrivals, Market
12.1 Kenya
12.2 Mauritius
12.3 Nigeria
12.4 Sudan
12.5 Tanzania

13. West Asia – Country Wise Medical Tourist Arrivals, Market
13.1 Iraq
13.2 Saudi Arabia
13.3 Yemen

14. South Asia
14.1 Bangladesh
14.2 Maldives
14.3 Nepal
14.4 Sri Lanka

15. South East Asia – Country Wise Medical Tourist Arrivals, Market
15.1 Myanmar

16. Australasia – Medical Tourist Arrivals, Market
16.1 Arrivals
16.2 Market

17. Others – Medical Tourist Arrivals, Market
17.1 Arrivals
17.2 Market

For more information about this report visit https://www.researchandmarkets.com/r/rx0vh

Attachment
```
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
```
November 23, 2022
With highly concentrated cannabinoids, BioHarvest takes aim at medical and dietary-supplement markets

Canadian and Israeli microcap biotech business BioHarvest Sciences Inc. has launched the initially hashish and hemp compositions manufactured through its proprietary bioreactor method.

BioHarvest
CNVCF,
-2.17{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}

BHSC,
-7.94{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}
works by using its bioreactor engineering to refine helpful compounds in hashish into concentrated doses for probable use in medicines and nutritional supplements.

According to unbiased third-social gathering information cited by the enterprise, BioHarvest has been in a position to boost the percentage of cannabinoids to 36{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c}, up from the 3{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} located in the plant, and to enhance the THC stage by 83 instances. It is also ready to boost more rare cannabinoids these kinds of as CBDV and THCV by 88 situations and 249 moments respectively, compared with a sampled hashish plant.

The process offers the capability to incorporate more substantial doses of CBDV and THCV, which includes what the company says is a “unique” 4-to-1 blend CBD/CBDV isolate that could be “disruptive” in the hemp-centered dietary-supplement market place.

“This would enable new hemp-based mostly therapeutical products and solutions, together with distillates, at a federally lawful nationwide stage in the U.S.,” BioHarvest mentioned. “The existence of important amounts of all other extra elusive cannabinoids could help deal with ADHD, soreness administration issues, and stress.”

BioHarvest isolates trichomes, which are the resin-generating glands on hashish and hemp flowers, and grows them in the lab. The procedure offers it the ability to “unlock uncommon cannabinoids not detectable in the plant,” the firm said.

Also examine: Hashish M&A cools but promotions continue to be on the desk regardless of scuttled Verano acquisition, analyst says

BioHarvest’s approach is also 54 periods more successful for every gallon of water than indoor hashish cultivation and 8 instances far more successful for electric power when compared with greenhouses, the enterprise explained. It features 19 times much more general manufacturing intensity than indoor cultivation.

BioHarvest CEO Ilan Sobel said the company’s products and process open the door to “many industrial applications.”

Chris D’Adamo, assistant professor at University of Maryland School of Medicine who directs the school’s integrative medicine study center, mentioned he’s noticed “considerable success” in patients addressed with CBD for suffering, anxiousness and stress.

Also go through: Hashish legalization goes up for a vote Nov. 8 in five states with a mixed grownup inhabitants of 13 million

BioHarvest’s capability to offer you a great deal larger doses of compounds this sort of as THCV and CBDV is desirable, D’Adamo mentioned.

“What bought me energized was the ability to tailor the CBD,” D’Adamo claimed. “I am incredibly amazed with the way they could escalate the uncommon cannabinoids.”

D’Adamo mentioned he was familiar with BioHarvest’s Vinia products, a dietary red grape/crimson wine focus that aims to increase cardiovascular well being. The organization is known for getting a sound scientific team, he mentioned.

Shares of BioHarvest are up 2{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} on Wednesday. The stock is down 34.9{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} in 2022, compared with a 28.8{fe463f59fb70c5c01486843be1d66c13e664ed3ae921464fa884afebcc0ffe6c} reduction by the Nasdaq. At previous test, the company’s market place capitalization was $107 million.

Also examine: Bronfman-backed Capsoil provides nano powder tech to hashish with initial edibles line

October 27, 2022

Tag: markets

India Medical Tourism Markets Report 2022: A $35.12 Billion Market by 2027

With highly concentrated cannabinoids, BioHarvest takes aim at medical and dietary-supplement markets